OXNAD1

Across TCGA pan-cancer cohorts, OXNAD1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated OXNAD1 data layer compared with 22 for mass-spec protein and 1 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher OXNAD1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated OXNAD1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LUAD show a favorable association.

HNSC, LUAD, and GBM are the cancer types where OXNAD1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	All	1.000	0.906	.003	12	view →
LUAD	DFS	Quartile	All	0.953	0.877	.014	7	view →
GBM	DFS	Tertile	All	0.226	0.593	.001	5	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

OXNAD1–HNSC (DFS)

Open the HNSC breakdown →